Side-by-side financials for CNTB and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CNTB | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $64.00K | - |
| Net income (latest FY) | -$55.48M | - |
| Net margin | -86687.5% | - |
| SEC filings | 180 | 1,004 |
Full pages: Connect Biopharma Holdings Ltd and AstraZeneca PLC, or browse the full rankings.